1Department of Acute Critical Care Medicine, Juntendo Shizuoka Hospital, Izunokuni, Japan
American Journal of Medical Case Reports.
2023,
Vol. 11 No. 2, 37-40
DOI: 10.12691/ajmcr-11-2-8
Copyright © 2023 Science and Education PublishingCite this paper: Ken-ichi Muramatsu, Ikuto Takeuchi, Soichiro Ota, Youichi Yanagawa. Transient Decrease of Insulin Secretion after COVID-19 Infection in a Patient with Hyperosmolar Hyperglycemic Syndrome.
American Journal of Medical Case Reports. 2023; 11(2):37-40. doi: 10.12691/ajmcr-11-2-8.
Correspondence to: Youichi Yanagawa, Department of Acute Critical Care Medicine, Juntendo Shizuoka Hospital, Izunokuni, Japan. Email:
yyanaga@juntendo.ac.jpAbstract
A 52-year-old male was transported to a local medical facility due to unconsciousness and involuntary movement. His past history included only hypertension. He consumed over 2 L of soft drink per day. His body mass index was 34. As he had hyperosmolar hyperglycemic syndrome and COVID-19 infection, he was transferred to our department. On arrival, he was in a coma and pre-shock state. He was therefore intubated. Initially, his blood C-peptide level was low, and he showed hyperglycemia with ketosis. Whole body computed tomography (CT) showed pneumonia. He was diagnosed with hyperosmolar hyperglycemic syndrome with ketosis, COVID-19 infection, convulsion, hemoconcentration, liver dysfunction, rhabdomyolysis, pancreatitis, renal failure and hypernatremia. He was admitted to the intensive care unit, where he was successfully treated. His blood C-peptide returned to the normal range (2.2 ng/mL) on day 20, and he returned to the local medical facility on day 21. This is the first report of transient decrease in insulin secretion after COVID-19 infection in a patient with a combination hyperosmolar hyperglycemic syndrome and ketosis. Further prospective studies are needed to clarify the characteristics of the insulin secretion function following COVID-19 infection.
Keywords